Peter Loskill received his PhD in physics from Saarland University in 2012 and subsequently conducted his postdoctoral research at UC Berkeley. In 2015, he was recognized by Technology Review as one of the “Innovators under 35 Germany” and was selected for the Fraunhofer ATTRACT funding program.
In 2016, he founded the µOrgano-Lab, whose interdisciplinary research combines approaches from engineering, biology, physics and medicine to develop novel microphysiological tissue models that recapitulate complex human biology in vitro and can be applied to answer for example scientific, toxicological or pharmaceutical research questions.